
Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data TAMPA, FL / ACCESS Newswire / July 29, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data and Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ('RWA') tokenization technologies, today announced that they have amended their definitive agreement with to expand its PharmacyChain blockchain-related technology licensing relationship beyond pharmaceutical distribution to include all unencumbered commercial healthcare, healthspan and wellness applications of Datavault AI's intellectual property. The expansion of the license prior to the closing of the proposed multi-party business combination that will also include Scilex Holdings and EOS Technology Holdings' QOLPOM patent portfolio and the acquisition of controlling interest in Tollo Health from HealthBridge Advisors was completed now to allow for the initiation of the Health Lives Here app private launch to NFL Alumni Health members at the 2026 Pro Football Hall of Fame Game in Canton, Ohio on Thursday, August 6, 2026.










